نتایج جستجو برای: glucantime

تعداد نتایج: 341  

Journal: :JPMA. The Journal of the Pakistan Medical Association 1998
F Rahim F Rehman S Ahmad B Zada

Visceral leishmaniasis is endemic in District Dir, NWFP. We evaluated 10 patients with visceral leishmaniasis at DHQ Hospital Timergara District Dir, N.W.F.P. All patients were in the age range 2 to 10 years. The predominant clinical features in these were chronic fever (10), splenomegaly (10), hepatomegaly (10), weight loss (10) and abdominal distention (5). Lymphadenopathy was absent. Common ...

Journal: :Revista da Sociedade Brasileira de Medicina Tropical 1988
J M Costa P D Marsden

Good drug trials in leishmaniasis with carefully controlled groups are rare. Recently Ballou et al1 were able to establish that 20mg Sbv/kg body wt for 20 days was more efficacious in closing leishmanial ulcers due to Leishmania braziliensis panamensis than lOmg Sb¥/kg/body wt for a similar period. Conditions for this trial were much more favourable than those where we work namely field clinics...

Journal: :The Journal of parasitology 2005
A Teva R Porrozzi M P Oliveira-Neto G Júnior Grimaldi

The antileishmanial efficacy of the reference drug N-methylglucamine antimoniate (Glucantime) was evaluated in groups of rhesus monkeys with acute and chronic Leishmania (Viannia) braziliensis cutaneous infection. The therapeutic responses in experimental animals to either a low dose (5 mg/kg body wt/day for 28 days) or a routine dose (20 mg/kg/day for 28 days) of pentavalent antimony were simi...

Faramarz Dobakhti, Fatemeh Partovi Ghader Khalili Hamid Mahmoudzadeh Niknam Vahid Khaze

Background: Leishmaniasis is a complex disease which presents as visceral, cutaneous and mucocutaneous forms. The current treatment options for this infection are very limited and the immunological state of the host appears to play an important role in the efficacy of the treatment. Immunostimulation through immune response activating agents such as Imiquimod is another rational approach for th...

A Asiliyan A Vali A.R GHafarinejhad F Iraji M.A Shah-Talebi

acute cutaneous leishmaniasis(ACL) is an endemic disease in developing countries.the first line drug for treatment of ACL.according to WHO recommendation,is the pentavalent antimony compounds such as meglumine antimoniate(Glucantime{SB}).high cost ,side effects,multiple injections and incomplete efficacy are limitations of this therapy.we evaluated the efficacy of intralesional(IL) injection of...

Journal: :Annals of parasitology 2015
Gamze Serarslan Metin Aksakal

Cutaneous leishmaniasis is a protozoan infectious disease and widespread in Mediterranean basin including Turkey. Lesions usually start with erythematous papules, gradually enlarges and afterwards it ulcerates. We present a 12-year-old boy with diffuse persistent lip swelling mimicking granulomatous cheilitis. Systemic glucantime was started. However, severe hypotension and bradycardia was deve...

2011
Nancy Saravia Olga Fernández Yira Díaz Clemencia Ovalle Sandra Muvdi Liliana Valderrama

Introduction Passive case detection and treatment constitute the principal and often the sole measure of control for dermal leishmaniasis in Central and South America yet pentavalent antimonials, the first line therapy, are often ineffective. Treatment failure is frequent and concerning in the management of cutaneous leishmaniasis in South America. Overall non-response is of the order of 24% ba...

اخوان, امیراحمد, ایراندوست, حسین, حجازی, سیدحسین, شارقی, نیلوفر, شیرانی بیدآبادی, لیلا, عبدلی, حمید, محبعلی, مهدی, محمودی, محسن, معطر, فریبرز, چاره دار, سرور,

Background and Aim: Leishmaniasis is a parasitic disease transmitted by sand-flies. Seventeen out of the 30 Iranian provinces are contaminated. Although many therapeutic modalities have been suggested, no definite treatment for this widespread infection is available. Many drugs currently used for cutaneous leishmaniasis have their side effects and create complications-drug resistance, etc. This...

ژورنال: Medical Laboratory Journal 2018
Dabirzadeh, Mansour , Farghi Yamchi , Asghar , Maroufi, Yahya,

ABSTRACT            Background and objectives: Leishmania major is a flagellated parasitic protozoan that causes cutaneous leishmaniasis. Pentavalent antimony compounds are considered the first-line drugs in the treatment of cutaneous leishmaniasis. However, the use of these drugs is associated with numerous limitations and side effects. Theref...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید